- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05135065
Community-Based Care for Minority Adolescents With ADHD: Improving Fidelity With Machine Learning-Assisted Supervision and Fidelity Feedback.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Y02 of this study is a small (N=72) phase 1/phase 2 clinical trial of a supervision intervention designed to improve therapist treatment fidelity and subsequent service delivery outcomes. The parallel design includes random assignment of eligible and consenting patients at three community agencies to two active supervision intervention arms (LC4S or ESAU) using a permuted block randomization strategy that accounts for agency. Participants will receive behavioral interventions from community agency staff and their service utilization will be tracked using project and agency electronic health records. Agency therapists and supervisors will also be participants in this trial. Therapists will be randomized to receive either LC4S or ESAU from their supervisor (double randomization) using a block randomization strategy that accounts for site. Supervisors will administer both supervision conditions in this trial; however, investigators will systematically assess for contamination to assess whether this design is appropriate for a future R01.
To minimize bias, adolescent and parent participants will not be informed of the group to which they have been assigned. However, full masking of therapists and supervisors is not feasible in this trial because both supervisors and therapists will know whether they are participating in technology-assisted supervision activities or standard supervision activities due to the nature of these conditions. However, the primary investigator will blind therapists and supervisors to our study hypotheses and the nature of outcome measures to minimize bias in the trial. Many of these measures will be observational and objective (i.e., therapy records, therapy audio recordings), which should reduce bias stemming from self-reports. Investigators will also assess whether there are group effects on therapist accuracy of self-report. All interventions will be delivered by agency staff, who will not be required to follow intervention delivery protocols because an outcome of this study is the extent to which agency therapists follow intervention procedures with guidance provided from their supervisors. Study assessments will be administered electronically via Care4 and data collection will be oversee by study staff.
Each measure of fidelity will be analyzed using a separate mixed /growth model (Duncan et al., 1999). In this design, treatment sessions (level 1) are nested within adolescents (level 2), which are nested within therapists (level 3). Each adolescent attends up to 10 sessions; each therapist treats 3 adolescents. Supervisors serve as an additional higher level, but with so few supervisors (approximately 6), this will be addressed by including dummy predictor variables representing the supervisors. The direct effect of LC4S vs. ESAU on fidelity intercept and slope will be tested for each fidelity outcome (see Table 3). With time centered at the first session, the intercept reflects initial fidelity for the ESAU condition, the group effect reflects the initial fidelity difference between ESAU and LC4S, the time effect reflects the linear change in fidelity over time for the ESAU condition, and the interaction of time and group reflects the difference between ESAU and LC4S in linear change in fidelity over time. As part of the R34, in will estimate the intraclass correlation (ICC) and design effect for the clustering effect of therapist and supervisor on outcome to determine the extent to which additional clustering will be needed in a future R01. ICC ranges from 0 to 1, with larger values reflecting a larger proportion of variance at the higher levels (here, therapist and supervisor rather than adolescent). Investigators will also test both linear and non-linear slopes to ascertain the expected shape of the LGCA in a future R01. Time to therapist MI competence, proportion of EBT delivered by 10th session, and number of sessions and days to completion of the EBT will be modeled using regression (linear, logistic, or Poisson depending on the distribution of the resulting variables) with group as a predictor. Accuracy of therapist self-report will be analyzed using polynomial regression (Laird & LaFleur, 2013).
Using the R package powerlmm, investigators have an estimate of .8 power to detect large effects (d = 0.8) representing group differences at the adolescent (level 2) level; investigators have .4 power to detect medium effects (d = .5) representing group differences at the adolescent level. Our hypotheses, however, are primarily at the level of the therapist (level 3), which has fewer units (i.e., 12 therapists per condition versus 36 adolescents per condition). As such, measures of both adolescent-level and therapist-level effects will be estimated. For power for the ICC calculation, investigators used the ICC.Sample.Size R package based on Zou (2012). With a sample size of 72 participants, 10 observations per participant, alpha equal to .05, and a two tailed test, investigators have greater than .9 power detect an ICC of 0.2. ICC values for cross-sectional data such as children within classrooms are approximately 0.2 (Hedges & Hedberg, 2007). Investigators expect excellent precision for estimating ICC values in this study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98145
- Seattle Children's Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- DSM-5 ADHD diagnosis, Enrollment in 6th-12th grade, IQ greater than 70, no history of autism spectrum disorder or thought disorder, client of one of two community mental health agencies
Exclusion Criteria:
- Autism Spectrum/Thought Disorders, IQ<70
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Artificial Intelligence-Assisted Supervision Protocol
Measurement-based supervision protocol that incorporates fidelity measurement from a machine learning tool and feedback reports from this tool into a standardized supervision protocol for behavior therapy to task-shift burdensome supervision tasks to a machine, reducing costs and improving precision of fidelity measurement for agencies.
|
Measurement-based supervision protocol that incorporates fidelity measurement from a machine learning tool and feedback reports from this tool into a standardized supervision protocol for behavior therapy to task-shift burdensome supervision tasks to a machine, reducing costs and improving precision of fidelity measurement for agencies.
|
|
No Intervention: Enhanced Supervision as Usual (ESAU) Condition
ESAU therapists will be given standard, paper-based facilitation resources for STAND and will receive 4 hours of training on how to navigate these materials and self-assess fidelity.
ESAU therapists will also be trained how to upload recordings into Care4 and complete self-assessments for each session.
Supervisors will be given access to these data and recordings once uploaded (but not Lyssn scores or electronic facilitation resources).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Therapist STAND Fidelity
Time Frame: Weekly for an average of 9 months
|
Behavior therapy content: STAND treatment fidelity checklists (Sibley et al., 2013, 2016, 2019).
This data will be collected via therapist self-report, Lyssn (the machine learning tool), and coded by trained research assistants from audio recordings.
If there is a discrepancy in sources, a trained RA will code the tape to resolve the discrepancy.
|
Weekly for an average of 9 months
|
|
Therapist MITI Fidelity
Time Frame: Weekly for an average of 9 months
|
Behavior therapy content:Motivational Interviewing Treatment Integrity (MITI) measure (Moyers et al., 2014) will measure MI integrity.This data will be collected via therapist self-report, Lyssn (the machine learning tool), and coded by trained research assistants from audio recordings.
If there is a discrepancy in sources, a trained RA will code the tape to resolve the discrepancy.
|
Weekly for an average of 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Service Delivery Quality
Time Frame: Weekly for duration that case is active in the agency, an average of 9 months
|
Quality: (1) Time to Therapist MI Competence; MITI Benchmarks,(Moyers et al., 2014) Accuracy of therapist self-report on MITI indices and fidelity checklists (tested using Polynomial Regression)--will assess concordance between reporters over time. This data will be collected from electronic health records and by coding audio recordings of therapy sessions. |
Weekly for duration that case is active in the agency, an average of 9 months
|
|
Service Delivery Quantity
Time Frame: Weekly for duration that case is active in the agency, an average of 9 months
|
Quantity: (2) Proportion of EBT delivered by 10th session Speed of Delivery: Number of sessions and days to completion of EBT.
This data will be collected from electronic health records and by coding audio recordings of therapy sessions.
|
Weekly for duration that case is active in the agency, an average of 9 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost
Time Frame: cost will be computed at the end of the year from study records and electronic heath records, an average of 9 months
|
Cost of implementing/subscribing to Care4/Lyssn; Supervisor/ therapist time , technical supports, stakeholder-identified costs
|
cost will be computed at the end of the year from study records and electronic heath records, an average of 9 months
|
|
Technology Acceptability
Time Frame: At end of the study, after an average of 9 months
|
Therapists and supervisors will complete an end of study questionnaire on the acceptability of the Lyssn Care4 Study protocol.
|
At end of the study, after an average of 9 months
|
|
Satisfaction with supervision
Time Frame: At end of the study, after an average of 9 months
|
The Short Supervisory Relationship Questionnaire (Cliffe et al., 2006), which will be completed by therapists and supervisors.
|
At end of the study, after an average of 9 months
|
|
Supervision Fidelity
Time Frame: Weekly, through study completion, an average of 9 months
|
We will adapt a project specific version of the Supervisor Adherence and Competence Scale (SACS; Martino et al., 2016), which will be completed by trained research assistants who listen to audio recordings.
In addition, we will train Lyssn to evaluate supervision sessions on this checklist by the end of the trial for potential use as supervisor feedback tool in a future R01.
|
Weekly, through study completion, an average of 9 months
|
|
Therapist engagement
Time Frame: Weekly, through study completion, an average of 9 months
|
Therapist Supervision Attendance: Supervisor logs of supervision dates/times; cancelations/reasons for cancelation; to be developed Weekly Facilitation Resources Use-measure; and completion rate for weekly Care4 support tasks (uploading session audio file and completing fidelity self-report form prior to supervision) forms are very brief questionnaires completed by therapists and supervisors prior to uploading each session in Care4 to measure therapist engagement with Care4 and Lyssn integrations
|
Weekly, through study completion, an average of 9 months
|
|
Supervisor Burden
Time Frame: Weekly, through study completion, an average of 9 months
|
Minutes discussing case on audio recording; supervisor log of prep work for case (not including research tasks).
Tapes will be coded by RAs for length and supervision logs will be kept by the supervisors.
|
Weekly, through study completion, an average of 9 months
|
|
Exit Interviews
Time Frame: At end of the study, after an average of 9 months
|
Semi-Structured exit interviews designed to collect qualitative perspectives on the LC4S intervention.
|
At end of the study, after an average of 9 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Margaret H Sibley, Ph.D, Seattle Children's Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R34MH125037 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Rutgers, The State University of New JerseyNational Institute of Mental Health (NIMH); Louisiana State University Health...Recruiting
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
Clinical Trials on Artificial Intelligence-Assisted Supervision Protocol
-
Renmin Hospital of Wuhan UniversityNot yet recruitingEndoscopic UltrasoundChina
-
Javier Santos FernándezCompletedColorectal Neoplasms | Colorectal Cancer | Adenoma Colon PolypSpain
-
Ovation FertilityIVF 2.0 LimitedRecruiting
-
The University of Hong KongUniversity Grants Committee, Hong KongCompleted
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownSleep Apnea | Coronary Heart Disease | Artificial IntelligenceChina
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Shenyang Northern HospitalRecruitingSTEMI - ST Elevation Myocardial InfarctionChina
-
Istanbul Medipol University HospitalTepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaboratorsRecruitingInflammatory Bowel Diseases | Colonoscopy | MicrobiotaTurkey
-
Peking University Third HospitalNot yet recruiting
-
Xinghua LiuNot yet recruitingSubclinical Anxious Adults | Subclinical Depression | Subclinical Emotional DistressChina